Literature DB >> 34720086

Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine.

Yajuan Zhang1, Hua Yu2, Jie Zhang3, Hong Gao1, Siyao Wang1, Shuxian Li3, Ping Wei4, Ji Liang1, Guanzhen Yu5, Xiongjun Wang2, Xinxiang Li6, Dawei Li6, Weiwei Yang1,7.   

Abstract

Although serine metabolism plays a crucial role in the proliferation and survival of tumor cells, how it supports tumor cell migration remains poorly understood. Phosphoglycerate dehydrogenase (PHGDH) catalyzes the oxidation of 3-phosphoglycerate to 3-phosphonooxypyruvate, the first committed step in de novo serine biosynthesis. Here we show that PHGDH was monoubiquitinated by cullin 4A-based E3 ligase complex at lysine 146 in colorectal cancer (CRC) cells, which enhanced PHGDH activity by recruiting a chaperone protein, DnaJ homolog subfamily A member 1, to promote its tetrameric formation, thereby increasing the levels of serine, glycine, and S-adenosylmethionine (SAM). Increased levels of SAM upregulated the expression of cell adhesion genes (laminin subunit gamma 2 and cysteine rich angiogenic inducer 61) by initiating SET domain containing 1A-mediated trimethylation of histone H3K4, thereby promoting tumor cell migration and CRC metastasis. Intriguingly, SAM levels in tumors or blood samples correlated with the metastatic recurrence of patients with CRC. Our finding not only reveals a potentially new role and mechanism of SAM-promoted tumor metastasis but also demonstrates a regulatory mechanism of PHGDH activity by monoubiquitination.

Entities:  

Keywords:  Amino acid metabolism; Cell migration/adhesion; Colorectal cancer; Metabolism; Oncology

Mesh:

Substances:

Year:  2021        PMID: 34720086      PMCID: PMC8553555          DOI: 10.1172/JCI146187

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Identification of substrates for F-box proteins.

Authors:  Jianping Jin; Xiaolu L Ang; Takahiro Shirogane; J Wade Harper
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

2.  Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.

Authors:  Jason W Locasale; Alexandra R Grassian; Tamar Melman; Costas A Lyssiotis; Katherine R Mattaini; Adam J Bass; Gregory Heffron; Christian M Metallo; Taru Muranen; Hadar Sharfi; Atsuo T Sasaki; Dimitrios Anastasiou; Edouard Mullarky; Natalie I Vokes; Mika Sasaki; Rameen Beroukhim; Gregory Stephanopoulos; Azra H Ligon; Matthew Meyerson; Andrea L Richardson; Lynda Chin; Gerhard Wagner; John M Asara; Joan S Brugge; Lewis C Cantley; Matthew G Vander Heiden
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

3.  Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.

Authors:  M L Kireeva; F E MO; G P Yang; L F Lau
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis.

Authors:  Li Ma; Yongzhen Tao; Angeles Duran; Victoria Llado; Anita Galvez; Jennifer F Barger; Elias A Castilla; Jing Chen; Tomoko Yajima; Aleksey Porollo; Mario Medvedovic; Laurence M Brill; David R Plas; Stefan J Riedl; Michael Leitges; Maria T Diaz-Meco; Adam D Richardson; Jorge Moscat
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

5.  In vitro histone methyltransferase assay.

Authors:  Ian M Fingerman; Hai-Ning Du; Scott D Briggs
Journal:  CSH Protoc       Date:  2008-02-01

6.  3-Phosphoglycerate dehydrogenase expression is regulated by HOXA10 in murine endometrium and human endometrial cells.

Authors:  Hongling Du; Danielle Vitiello; Jennifer L Sarno; Hugh S Taylor
Journal:  Reproduction       Date:  2010-01       Impact factor: 3.906

7.  Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles.

Authors:  Thomas Schmidt; Andreas Leha; Gabriela Salinas-Riester
Journal:  Gene       Date:  2016-09-26       Impact factor: 3.688

8.  Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.

Authors:  Jie Zhang; Pengxing He; Yong Xi; Meiyu Geng; Yi Chen; Jian Ding
Journal:  Oncotarget       Date:  2015-02-20

9.  PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.

Authors:  Debangshu Samanta; Youngrok Park; Shaida A Andrabi; Laura M Shelton; Daniele M Gilkes; Gregg L Semenza
Journal:  Cancer Res       Date:  2016-06-08       Impact factor: 12.701

10.  PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.

Authors:  Fabao Liu; Fengfei Ma; Yuyuan Wang; Ling Hao; Hao Zeng; Chenxi Jia; Yidan Wang; Peng Liu; Irene M Ong; Baobin Li; Guojun Chen; Jiaoyang Jiang; Shaoqin Gong; Lingjun Li; Wei Xu
Journal:  Nat Cell Biol       Date:  2017-10-23       Impact factor: 28.824

View more
  4 in total

Review 1.  Monoubiquitination in Homeostasis and Cancer.

Authors:  Yujie Chen; Dandan Zhou; Yinan Yao; Yutong Sun; Fan Yao; Li Ma
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

2.  Metagenomic and metabolomic analyses reveal synergistic effects of fecal microbiota transplantation and anti-PD-1 therapy on treating colorectal cancer.

Authors:  Jiayuan Huang; Xing Zheng; Wanying Kang; Huaijie Hao; Yudan Mao; Hua Zhang; Yuan Chen; Yan Tan; Yulong He; Wenjing Zhao; Yiming Yin
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

3.  SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma.

Authors:  Weiyu Kong; Zhongyuan Wang; Nuoran Chen; Yiwen Mei; Yang Li; Yulin Yue
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

4.  A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.

Authors:  Le Liu; Liping Liang; Genghui Mai; Ye Chen
Journal:  FASEB Bioadv       Date:  2022-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.